The mechanism underlying the synergetic hypocholesterolemic effect of sesamin and α-tocopherol in rats fed a high-cholesterol diet

Journal of Pharmacological Sciences

Volumn 115, Issue 3, 2011, Pages 408-416

  Rogi, Tomohiro ^a   Tomimori, Namino ^a   Ono, Yoshiko ^a   Kiso, Yoshinobu ^a  

^a Suntory Wellness Limited Research Center   (Japan)

Author keywords

Apolipoprotein; ATP binding cassette transporter; Hypocholesterolemic activity; Sesamin; tocopherol

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER B11; ABC TRANSPORTER B4; ABC TRANSPORTER G1; ABC TRANSPORTER G5; ABC TRANSPORTER G8; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL TRANSFER PROTEIN; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; CARRIER PROTEIN; CHOLESTEROL; CYTOCHROME P450; CYTOCHROME P450 4F2; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; SESAMIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG LIVER LEVEL; DRUG POTENTIATION; DRUG STRUCTURE; FOOD COMPOSITION; GENE; GENE EXPRESSION PROFILING; INSULIN INDUCED GENE 1; INSULIN INDUCED GENE 2; MALE; MOLECULAR MECHANICS; NONHUMAN; PROTEIN SECRETION; RAT;

EID: 79952779115     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10287FP     Document Type: Article

References (41)

1. Shimizu S, Akimoto K, Shinmen Y, Kawashima H, Sugan M, Yamada H. Sesamin is a potent and specific inhibitor of delta 5 desaturase in polyunsaturated fatty acid biosynthesis. Lipids. 1991;26:512-516.
2. Shimizu S, Akimoto K, Shinmen Y, Sugano M, Yamada H. Production of dihomo-γ-linolenic acid by Mortierella alpina 1S-4. J Am Oil Chem Soc. 1989;66:237-241.
3. Fukuda Y, Nagata T, Osawa T, Namiki M. Contribution of lignan analogues to antioxidative activity of refined unroasted sesame seed oil. J Am Oil Chem Soc. 1986;63:1027-1031. (Pubitemid 16609713)
4. Ikeda S, Kagaya M, Kobayashi K, Tohyama T, Kiso Y, Higuchi N, et al. Dietary sesame lignans decrease lipid peroxidation in rats fed docosahexaenoic acid. J Nutr Sci Vitaminol. 2003;49:270-276. (Pubitemid 37129117)
5. Hirose N, Doi F, Ueki T, Akazawa K, Chijima K, Sugano M, et al. Suppressive effect of sesamin against 7,12-dimethylbenz-[a]anthracene-induced rat mammary carcinogenesis. Anticancer Res. 1992;12:1259-1265.
6. Matsumura Y, Kita S, Morimoto S, Akimoto K, Furuya M, Oka N, et al. Antihypertensive effect of sesamin. I. Protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy. Biol Pharm Bull. 1995;18:1016-1019.
7. Kita S, Matsumura Y, Morimoto S, Akimoto K, Furuya M, Oka N, et al. Antihypertensive effect of sesamin. II. Protection against two-kidney, one-clip renal hypertension and cardiovascular hypertrophy. Biol Pharm Bull. 1995;18:1283-1285
8. Matsumura Y, Kita S, Tanide Y, Taguchi Y, Morimoto S, Akimoto K, et al. Antihypertensive effect of sesamin. III. Protection against development and maintenance of hypertension in stroke-prone spontaneously hypertensive rats. Biol Pharm Bull. 1998;21:469-473.
9. Nakano D, Itoh C, Ishii F, Kawanishi H, Takaoka M, Kiso Y, et al. Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats. Biol Pharm Bull. 2003;26:1701-1705. (Pubitemid 39663529)
10. Nakano D, Kurumazuka D, Nagai Y, Nishiyama A, Kiso Y, Matsumura Y. Dietary sesamin suppresses aortic NADPH oxidase in DOCA salt hypertensive rats. Clin Exp Pharmacol Physiol. 2008;35:324-326. (Pubitemid 351257874)
11. Miyawaki T, Aono H, Toyoda-Ono Y, Maeda H, Kiso Y, Moriyama K. Antihypertensive effects of sesamin in humans. J Nutr Sci Vitaminol. 2009;55:87-91.
12. Hirose N, Inoue T, Nishihara K, Sugano M, Akimoto K, Shimizu S, et al. Inhibition of cholesterol absorption and synthesis in rats by sesamin. J Lipid Res. 1991;32:629-638.
13. Ashakumary L, Rouyer I, Takahashi Y, Ide T, Fukuda N, Aoyama T, et al. Sesamin, a sesame lignan, is a potent inducer of hepatic fatty acid oxidation in the rat. Metabolism. 1999;48:1303-1313. (Pubitemid 29496080)
14. Hirata F, Fujita K, Ishikura Y, Hosoda K, Ishikawa T, Nakamura H. Hypocholesterolemic effect of sesamin lignan in humans. Atherosclerosis. 1996;122:135-136. (Pubitemid 26132629)
15. Nakabayashi A, Kitagawa Y, Suwa Y, Akimoto K, Asami S, Shimizu S, et al. alpha-Tocopherol enhances the hypocholesterolemic action of sesamin in rats. Int J Vitam Nutr Res. 1995;65:162-168.
16. Yamashita K, Nohara Y, Katayama K, Namiki M. Sesamin seed lignans and gamma-tochopherol act synergistically to produce vitamin E activity in rats. J Nutr. 1992;122:2440-2446. (Pubitemid 23004643)
17. Yamashita K, Iizuka Y, Imai T, Namiki M. Sesame seed and its lignans produce marked enhancement of vitamin E activity in rats fed a low alpha-tocopherol diet. Lipids. 1995;30:1019-1028.
18. Tsuruoka N, Kidokoro A, Matsumoto I, Abe K, Kiso Y. Modulating effect of sesamin, a functional lignan in sesame seeds, on the transcription levels of lipid- and alcohol-metabolizing enzymes in rat liver: a DNA microarray study. Biosci Biotechnol Biochem. 2005;69:179-188. (Pubitemid 40383498)
19. Noguchi T, Ikeda K, Sasaki Y, Yamamoto J, Seki J, Yamagata K, et al. Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Hypertens Res. 2001;24:735-742. (Pubitemid 33133790)
20. Kong X, Yang JR, Guo LQ, Xiong Y, Wu XQ, Huang K, et al. Sesamin improves endothelial dysfunction in renovascular hypertensive rats fed with a high-fat, high-sucrose diet. Eur J Pharmacol. 2009;620:84-89.
21. Khan MM, Ishrat T, Ahmad A, Hoda MN, Khan MB, Khuwaja G, et al. Sesamin attenuates behavioral, biochemical and histological alterations induced by reversible middle cerebral artery occlusion in the rats. Chem Biol Interact. 2010;183:255-263.
22. Ide T, Nakashima Y, Iida H, Yasumoto S, Katsuta M. Lipid metabolism and nutrigenomics - impact of sesame lignans on gene expression profiles and fatty acid oxidation in rat liver. Forum Nutr. 2009;61:10-24.
23. Ide T, Lim JS, Odbayar TO, Nakashima Y. Comparative study of sesame lignans (sesamin, episesamin and sesamolin) affecting gene expression profile and fatty acid oxidation in rat liver. J Nutr Sci Vitaminol. 2009;55:31-43.
24. Akimoto K, Asami S, Shimizu S, Sugano M, Yamada H. Antioxidant activity of sesamin on NADPH-dependent peroxidation in liver microsomes. In: Kumpulainen JT, Salonen JT, editors. Natural antioxidants and food quality in atherosclerosis and cancer prevention. London: The Royal Society of Chemistry; 1996. p. 241-246.
25. Nakai M, Harada M, Nakahara K, Akimoto K, Shibata H, Miki W, et al. Novel antioxidative metabolites in rat liver with ingested sesamin. J Agric Food Chem. 2003;51:1666-1670.
26. Akimoto K, Kigawa Y, Akamatsu T, Hirose N, Sugano M, Shimizu S, et al. Protective effects of sesamin against liver damage caused by alcohol or carbon tetrachloride in rodents. Ann Nutr Metab. 1993;37:218-224. (Pubitemid 23240775)
27. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 2000;290:1771-1775. (Pubitemid 32004809)
28. Lu K, Lee MH, Hazard S, Brooks-Wilson A, Hidaka H, Kojima H, et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet. 2001;69:278-290. (Pubitemid 32695201)
29. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A. 2002;99:16237-16242. (Pubitemid 35462779)
30. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest. 2002;110:671-680. (Pubitemid 34988791)
31. Wright KL, White LC, Kelly A, Beck S, Trowsdale J, Ting JP. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J Exp Med. 1995;181:1459-1471.
32. Pollner R, Schmidt C, Fischer G, Kühn K, Pöschl E. Cooperative and competitive interactions of regulatory elements are involved in the control of divergent transcription of human Col4A1 and Col4A2 genes. FEBS Lett. 1997;405:31-36. (Pubitemid 27130367)
33. Ryan MT, Herd SM, Sberna G, Samuel MM, Hoogenraad NJ, Hoj PB. The genes encoding mammalian chaperonin 60 and chaperonin 10 are linked head-to-head and share a bidirectional promoter. Gene. 1997;196:9-17. (Pubitemid 27380089)
34. Remaley AT, Bark S, Walts AD, Freeman L, Shulenin S, Annilo T, et al. Comparative genome analysis of potential regulatory elements in the ABCG5-ABCG8 gene cluster. Biochem Biophys Res Commun. 2002;295:276-282. (Pubitemid 34785829)
35. Sumi K, Tanaka T, Uchida A, Magoori K, Urashima Y, Ohashi R, et al. Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8. Mol Cell Biol. 2007;27:4248-4260. (Pubitemid 46906550)
36. Freeman LA, Kennedy A, Wu J, Bark S, Remaley AT, Santamarina-Fojo S, et al. The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter. J Lipid Res. 2004;45:1197-1206. (Pubitemid 38802623)
37. Gallagher JW, Weinberg RB, Shelness GS. apoA-IV tagged with the ER retention signal KDEL perturbs the intracellular trafficking and secretion of apoB. J Lipid Res. 2004;45:1826-1834. (Pubitemid 40990874)
38. Ikeda S, Tohyama T, Yamashita K. Dietary sesame seed and its lignans inhibit 2,7,8-trimethyl- 2(2′-carboxyethyl)-6-hydroxychroman excretion into urine of rats fed gamma-tocopherol. J Nutr. 2002;132:961-966.
39. Sontag TJ, Parker RS. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem. 2002;277:25290-25296. (Pubitemid 34951838)
40. Pignone M. Primary prevention: dyslipidaemia. Clin Evid. 2005;14:142-150.
41. Gami A. Secondary prevention of ischaemic cardiac events. Clin Evid. 2006;15:195-228.